HAROON KHAN: Open Payments
NPI 1225293384 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,852 in 143 payments from 25 companies in 2025. Trend: 2023 $1,946 · 2024 $2,330 · 2025 $2,852
Food & beverage: $2,852
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 36 | $511 |
| BIOTRONIK INC. | 5 | $370 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $295 |
| Kestra Medical Technology Services, Inc. | 5 | $202 |
| CVRx, Inc. | 3 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $181 |
| Novo Nordisk Inc | 13 | $149 |
| Medtronic, Inc. | 1 | $146 |
| E.R. Squibb & Sons, L.L.C. | 23 | $145 |
| Merck Sharp & Dohme LLC | 8 | $134 |
Products named: LEQVIO, LifeVest, Assure WCD, Barostim Neo System, JARDIANCE, BIOMONITOR, ENDURANT IIS, CAMZYOS.
Industry payments across NJ — which companies pay providers there.
